RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Carmen Melendez-Vasquez to Rats

This is a "connection" page, showing publications Carmen Melendez-Vasquez has written about Rats.
Connection Strength

0.484
  1. Urbanski MM, Kingsbury L, Moussouros D, Kassim I, Mehjabeen S, Paknejad N, Melendez-Vasquez CV. Myelinating glia differentiation is regulated by extracellular matrix elasticity. Sci Rep. 2016 09 20; 6:33751.
    View in: PubMed
    Score: 0.082
  2. Lim H, Sharoukhov D, Kassim I, Zhang Y, Salzer JL, Melendez-Vasquez CV. Label-free imaging of Schwann cell myelination by third harmonic generation microscopy. Proc Natl Acad Sci U S A. 2014 Dec 16; 111(50):18025-30.
    View in: PubMed
    Score: 0.073
  3. Wang H, Rusielewicz T, Tewari A, Leitman EM, Einheber S, Melendez-Vasquez CV. Myosin II is a negative regulator of oligodendrocyte morphological differentiation. J Neurosci Res. 2012 Aug; 90(8):1547-56.
    View in: PubMed
    Score: 0.060
  4. Leitman EM, Tewari A, Horn M, Urbanski M, Damanakis E, Einheber S, Salzer JL, de Lanerolle P, Melendez-Vasquez CV. MLCK regulates Schwann cell cytoskeletal organization, differentiation and myelination. J Cell Sci. 2011 Nov 15; 124(Pt 22):3784-96.
    View in: PubMed
    Score: 0.059
  5. Wang H, Tewari A, Einheber S, Salzer JL, Melendez-Vasquez CV. Myosin II has distinct functions in PNS and CNS myelin sheath formation. J Cell Biol. 2008 Sep 22; 182(6):1171-84.
    View in: PubMed
    Score: 0.047
  6. Melendez-Vasquez CV, Einheber S, Salzer JL. Rho kinase regulates schwann cell myelination and formation of associated axonal domains. J Neurosci. 2004 Apr 21; 24(16):3953-63.
    View in: PubMed
    Score: 0.035
  7. Melendez-Vasquez CV, Rios JC, Zanazzi G, Lambert S, Bretscher A, Salzer JL. Nodes of Ranvier form in association with ezrin-radixin-moesin (ERM)-positive Schwann cell processes. Proc Natl Acad Sci U S A. 2001 Jan 30; 98(3):1235-40.
    View in: PubMed
    Score: 0.028
  8. Mel?ndez-V?squez CV, Gregson NA. Characterization and partial purification of a novel 36 kDa peripheral myelin protein recognized by the sera of patients with neurological disorders. J Neuroimmunol. 1998 Nov 02; 91(1-2):10-8.
    View in: PubMed
    Score: 0.024
  9. Mel?ndez-V?squez C, Redford J, Choudhary PP, Gray IA, Maitland P, Gregson NA, Smith KJ, Hughes RA. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol. 1997 Mar; 73(1-2):124-34.
    View in: PubMed
    Score: 0.021
  10. Dutta DJ, Zameer A, Mariani JN, Zhang J, Asp L, Huynh J, Mahase S, Laitman BM, Argaw AT, Mitiku N, Urbanski M, Melendez-Vasquez CV, Casaccia P, Hayot F, Bottinger EP, Brown CW, John GR. Combinatorial actions of Tgf? and Activin ligands promote oligodendrocyte development and CNS myelination. Development. 2014 Jun; 141(12):2414-28.
    View in: PubMed
    Score: 0.018
  11. He Y, Kim JY, Dupree J, Tewari A, Melendez-Vasquez C, Svaren J, Casaccia P. Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination. Nat Neurosci. 2010 Dec; 13(12):1472-80.
    View in: PubMed
    Score: 0.014
  12. Zhang Y, Taveggia C, Melendez-Vasquez C, Einheber S, Raine CS, Salzer JL, Brosnan CF, John GR. Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. J Neurosci. 2006 Nov 22; 26(47):12174-85.
    View in: PubMed
    Score: 0.010
  13. Rios JC, Melendez-Vasquez CV, Einheber S, Lustig M, Grumet M, Hemperly J, Peles E, Salzer JL. Contactin-associated protein (Caspr) and contactin form a complex that is targeted to the paranodal junctions during myelination. J Neurosci. 2000 Nov 15; 20(22):8354-64.
    View in: PubMed
    Score: 0.007
  14. Gonzalez LE, Mel?ndez-V?squez CV, Gregson NA, File SE. A rat model of spontaneous myopathy and malignant hyperthermia. Am J Pathol. 1998 Apr; 152(4):1099-103.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support